Due to the fact that there is a clinical trial still in progress and the information is deemed confidential that could move a share price, i would say that the information will be shared at the conference as a big reveal ( who knows ).
The IONIC trial is taking place across six sites in the Sydney area and regional NSW. The current patient
cohort is being treated with a Veyonda dose of 1800mg, which is the highest so far and the fact that the trial has been going on for more than 16 months they should definitely have some efficacy results, Why present it at ASCO if it's crap news that's my view.
Ann: Change of Director's Interest Notice - FB, page-9
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $15.23K | 145.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7857 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |